COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

Bleeding Management and Use of Anticoagulants: Panel Discussion

PERT Consortium 2021

G. Piazza, M. McDaniel, M. Huisman, D. Siegal, C. Pollack

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Pulmonary Embolism During Pregnancy

Pulmonary Embolism 2016

J. Bartholomew

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

TCT 2022 Conference Coverage

W. Jaber

Extended Anticoagulation for VTE

Jeffrey Weitz

Pulmonary Arterial Hypertension- Past, Present, & Future

AdventHealth

S. Mandras

CHEST 2024 Insights: (Mechanical) Support in RV Failure - Let's Keep…

CHEST Annual Meeting Insights

A. Vaidya

Pulmonary Embolism: Where Are We in 2024?

UPMC

B. Rivera-Lebron

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Mount Sinai Endovascular Fellows Course

J. Giri

Long Term Anticoagulation - How and For How Long?

Pulmonary Embolism Symposium (PERT 2017)

Pulmonary Manifestations of SLE: An Update

Keck School of Medicine of USC

F. Quismorio

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

Catheter-Directed Thrombolysis Is the Preferred Approach for the Tre…

PERT Consortium 2022

P. Monteleone

Regulatory Pathways for Devices for Management of Pulmonary Embolism…

PERT Consortium 2021

S. Lossef

Metabolic Interventions in PAH

Cleveland Clinic Respiratory Institute

A. R Hemnes

ACC 2023: Clinical Manifestations of Right Ventricular Failure

ACC 2023 Conference Coverage

J. Huston